This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ITS USE IN THE TREATMENT OF DIABETES

A. I. RINGER, M.D.; S. BILOON, M.D.; M. M. HARRIS, M.D.; A. LANDY, M.D.

Arch Intern Med. 1928;41(4):453-471.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since the introduction of insulin in the treatment of patients with diabetes, various investigations have been conducted to find a remedy which would exert an influence on diabetes similar to that of insulin, but which could be administered orally.

During the course of the last year, a synthetic compound named "synthalin" was developed by Frank¹ in Minkowski's clinic² in Breslau. The exact chemical composition of this substance is deca-methyl-diguanidine,

In their first communication, these authors report that they were able to reduce the blood sugar concentration in completely depancreatized dogs and rabbits by administering synthalin either subcutaneously or orally. In these animals the blood dextrose dropped from 314 mg. per hundred cubic centimeters of blood to 70, and from 426 to 90. The clinical symptoms of hypoglycemia, convulsions and general paralysis, from which the animals recovered on the administration of dextrose, accompanied this drop in the blood sugar.

In their . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Medical Division of the Montefiore Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?